Cedro Armando

Title: Innovations by Cedro Armando in the Field of Oligodeoxyribonucleotides

Introduction

Cedro Armando is a notable inventor based in Milan, Italy, recognized for his contributions to the field of biochemistry. He has been instrumental in developing new oligodeoxyribonucleotides that have significant medical applications, particularly in treating cardiac ischemia. With a total of two patents to his name, Armando's work is paving the way for advancements in therapeutic treatments.

Latest Patents

Armando's latest patents include innovations related to hydrolytically processed oligodeoxyribonucleotides. The first patent discloses new oligodeoxyribonucleotides of animal origin, characterized by a molecular weight between 4000 and 10000 daltons. These compounds can be obtained through the fractionation of polydeoxyribonucleotides or by chemical or enzymatic depolymerization of high molecular weight deoxyribonucleic acids. Notably, these new compounds exhibit significant anti-ischemic activity. The second patent also focuses on oligodeoxyribonucleotides of animal origin, emphasizing their potential in treating cardiac ischemia through similar methods of extraction and processing.

Career Highlights

Cedro Armando is currently associated with Crinos Industria Farmacobiologica S.p.a., where he continues to innovate in the field of pharmaceuticals. His work has garnered attention for its potential impact on medical treatments, particularly in cardiology.

Collaborations

Armando collaborates with esteemed colleagues such as Lanzarotti Ennio and Mantovani Marisa, contributing to a dynamic research environment that fosters innovation and development in biopharmaceuticals.

Conclusion

Cedro Armando's contributions to the field of oligodeoxyribonucleotides represent significant advancements in medical science. His innovative patents and collaborative efforts are paving the way for new treatments that could greatly benefit patients suffering from cardiac conditions.